Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Tesaglitazar improves abnormalities in nondiabetic patients with insulin resistance

May 25, 2005

Aegis and Albany Medical College to develop antiobesity nasal spray

May 24, 2005

Thrombopoietin, erythropoietin receptor agonists revealed in patent literature

May 23, 2005

Abstracts describe efficacy of DX-88 in HAE

May 23, 2005

Phase II/III results with recombinant human C1 inhibitor in HAE

May 23, 2005

Bradykinin B1 receptor antagonism reduces diabetic vascular complications in rats

May 20, 2005

Schering AG announces new treatment option for infertility

May 20, 2005

New treatments for obesity disclosed

May 20, 2005

Alliance to pursue proof-of-concept study for Oxygent

May 20, 2005

New phase II study for PN-2034 in type 2 diabetes

May 20, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 21, 2026.
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...